Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,390,320
-$10,772,647 QoQ
Shares Held
231,709
-23.6% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Evelyn Partners Investment Management LLP holds $27,828,895 across 4 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (98.4% of the industry book) .
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,390,320 | 231,709 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,162,967 | 303,314 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $49,870,391 | 340,831 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $63,430,947 | 406,739 | Shares | Sole | 2025-11-26 | |
| 2025-03-31 | $65,929,976 | 400,425 | Shares | Sole | 2025-12-08 | |
| 2024-12-31 | $61,464,364 | 377,244 | Shares | Sole | 2025-12-11 | |
| No filing history on record for this holder in this stock. | ||||||